Skip to content
10-Q

Quarterly Report

iBio, Inc. IBIO

0001104659-26-059416

← back to feed
Filed
May 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2026 · May 12, 2026 49.68M sh
Shares Diluted Q3 2026 · Mar 31, 2026 119.6M sh
Shares Diluted Q3 2026 · Mar 31, 2026 90.3M sh
Shares Diluted Q3 2026 · Mar 31, 2025 9.86M sh
Shares Diluted Q3 2026 · Mar 31, 2025 9.2M sh
Capex Q3 2026 · Mar 31, 2026 $559K
Capex Q3 2026 · Mar 31, 2025 $15K
Operating Cash Flow Q3 2026 · Mar 31, 2026 −$16.99M
Operating Cash Flow Q3 2026 · Mar 31, 2025 −$10.69M
Cash And Equivalents Q3 2026 · Mar 31, 2026 $47.63M
Cash And Equivalents Q3 2026 · Jun 30, 2025 $8.58M
Stockholders Equity Q3 2026 · Mar 31, 2026 $77.54M
Stockholders Equity Q3 2026 · Jun 30, 2025 $14.88M
Current Liabilities Q3 2026 · Mar 31, 2026 $6.5M
Current Liabilities Q3 2026 · Jun 30, 2025 $6.11M
Total Liabilities Q3 2026 · Mar 31, 2026 $8.3M
Total Liabilities Q3 2026 · Jun 30, 2025 $8.31M
Current Assets Q3 2026 · Mar 31, 2026 $77.25M
Current Assets Q3 2026 · Jun 30, 2025 $9.72M
Total Assets Q3 2026 · Mar 31, 2026 $85.83M
Total Assets Q3 2026 · Jun 30, 2025 $23.19M
Eps Diluted Q3 2026 · Mar 31, 2026 −$0.06
Eps Diluted Q3 2026 · Mar 31, 2026 −$0.25
Eps Diluted Q3 2026 · Mar 31, 2025 −$0.49
Eps Diluted Q3 2026 · Mar 31, 2025 −$1.44
Eps Basic Q3 2026 · Mar 31, 2026 −$0.06
Eps Basic Q3 2026 · Mar 31, 2026 −$0.25
Eps Basic Q3 2026 · Mar 31, 2025 −$0.49
Eps Basic Q3 2026 · Mar 31, 2025 −$1.44
Sga Expense Q3 2026 · Mar 31, 2026 $5.11M
Sga Expense Q3 2026 · Mar 31, 2026 $12.78M
Sga Expense Q3 2026 · Mar 31, 2025 $2.97M
Sga Expense Q3 2026 · Mar 31, 2025 $8.52M
Rd Expense Q3 2026 · Mar 31, 2026 $3.25M
Rd Expense Q3 2026 · Mar 31, 2026 $11.08M
Rd Expense Q3 2026 · Mar 31, 2025 $1.91M
Rd Expense Q3 2026 · Mar 31, 2025 $5.09M
Net Income Q3 2026 · Mar 31, 2026 −$7.73M
Net Income Q3 2026 · Mar 31, 2026 −$22.44M
Net Income Q3 2026 · Dec 31, 2025 −$8.99M
Net Income Q3 2026 · Sep 30, 2025 −$5.72M
Net Income Q3 2026 · Mar 31, 2025 −$4.86M
Net Income Q3 2026 · Mar 31, 2025 −$13.21M
Net Income Q3 2026 · Dec 31, 2024 −$4.36M
Net Income Q3 2026 · Sep 30, 2024 −$3.99M
Operating Income Q3 2026 · Mar 31, 2026 −$8.37M
Operating Income Q3 2026 · Mar 31, 2026 −$23.76M
Operating Income Q3 2026 · Mar 31, 2025 −$4.88M
Operating Income Q3 2026 · Mar 31, 2025 −$13.4M
Revenue Q3 2026 · Mar 31, 2026 $100K
Revenue Q3 2026 · Mar 31, 2025 $200K